Cargando…
Designing HIV Vaccine Efficacy Trials in the Context of Highly Effective Non-vaccine Prevention Modalities
The evolving HIV prevention landscape poses challenges to the statistical design of future trials of candidate HIV vaccines. Study designs must address the anticipated reduction in HIV incidence due to adding new prevention modalities to the standard prevention package provided to trial participants...
Autores principales: | Janes, Holly, Zhu, Yifan, Brown, Elizabeth R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022814/ https://www.ncbi.nlm.nih.gov/pubmed/36938334 http://dx.doi.org/10.1007/s12561-020-09292-1 |
Ejemplares similares
-
Assessing correlates of protection in vaccine trials: statistical solutions in the context of high vaccine efficacy
por: Callegaro, Andrea, et al.
Publicado: (2019) -
P14-07. Offering new prevention modalities in HIV vaccine trials: experience with male circumcision in the Phambili trial
por: de Bruyn, G, et al.
Publicado: (2009) -
Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa
por: Malahleha, Mookho, et al.
Publicado: (2023) -
Challenges in the Design of a T Cell Vaccine in the Context of HIV-1 Diversity
por: Tongo, Marcel, et al.
Publicado: (2014) -
Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 Transmission
por: Swan, David A., et al.
Publicado: (2021)